Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-09-25

FDA Approved: GALAFOLD — Supplemental Application (Amicus Therapeutics US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for GALAFOLD (migalastat hydrochloride) submitted by Amicus Therapeutics US, LLC to update its labeling. This action…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GALAFOLD (MIGALASTAT HYDROCHLORIDE)

Snippet

SUPPL AP for GALAFOLD (MIGALASTAT HYDROCHLORIDE)